VLON - GRI Bio Inc

0.4049
0.405   100.000%

Share volume: 0
Last Updated: 04-21-2023

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Historical prices Events Documents Notes Dividends
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
24.13%
6 Months
-43.82%
1 Year
-43.82%
2 Year
43.14%
Key data
Stock price
$0.40
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.34 - $0.80
52 WEEK CHANGE
-$43.82
MARKET CAP 
9.707 B
YIELD 
N/A
SHARES OUTSTANDING 
13.482 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO:
Region: US
Website: www.vallon-pharma.com
Employees: 2
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Vallon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company, headquartered in Philadelphia, PA. The Company is focused on the development of new medications to help patients with central nervous system (CNS) disorders. The Company’s lead investigational product candidate, ADAIR, is a novel abuse deterrent formulation of amphetamine immediate release being developed for the treatment of ADHD and narcolepsy.

Recent news